Washington Economic Development Finance to offer $118.2 million of revenue refunding bonds

By Cristal Cody

Tupelo, Miss., July 18 – The Washington Economic Development Finance Authority is expected to price $118,215,000 of lease revenue refunding bonds (Aa1/AA+/) for Washington Biomedical Research Properties II, according to a preliminary official statement.

The deal includes $111,755,000 of series 2014A bonds with serial maturities from 2015 through 2038 and $6.46 million of series 2014B bonds due in 2015 and 2016.

Barclays is the lead manager of the negotiated offering. Citigroup Global Markets Inc. and BofA Merrill Lynch are co-managers.

Proceeds will be used to defease and refund outstanding series 2005E and series 2006J lease revenue bonds.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.